HOIST Co.,Ltd. | A pioneering drug discovery venture company promoting the development of novel cancer drugs using innovative technology.

A pioneering drug discovery venture company promoting the development of novel cancer drugs using innovative technology.

News & Topics

2024.03.25: Details of the efficacy evaluation of HM-001 will be presented in a poster presentation at the AACR Special Conference in Cancer Research: Bladder Cancer in May 2024.
2024.03.25: A poster presentation on drug development utilizing MA-T system (HM-001) will be presented at AACR (American Association for Cancer Research) in April 2024.
2023.10.05: We will exhibit at BioJapan2023

Our vision

To sail into a new dimension where further advance the existing medical system, treatment methods, and economic rationality through innovative research results and exploratory research, by breaking with conventional wisdom and.

Mission statement

To create or discover innovative anti-cancer drugs through industry-academia collaboration and achieve a high quality of life after anti-cancer treatment without anxiety for those treated. Through these efforts, we will contribute to a society that can improve the age of health and respond to changes in social structure.

Value

We will not be bound by preconceived ideas, but will Approach all cancer treatments from a new perspective.
Challenge areas where treatment is becoming more prolonged, rather than focusing solely on the size of the market potential.
Contribute to reduce the burden on patients by economically rational treatment drugs.
Leap to a new dimension with new ideas and perspectives on cancer treatment.

A.C.C.L. is our Value.

Corporate Philosophy

Pursuit of Innovation
Contribution to Society
Human Resource Development and Succession

Guidelines for our actions

Don't set limits for yourself
Walk one step ahead of others
Always keep efficiency in mind
Share the joy with your friends
Question your own actions once
Don't jump at the chance to innovate without getting the basics down
Act calmly and boldly

Message

Our Thoughts

CEO Message

President and CEO
CHIHAYA KAKINUMA, Ph.D.

Founder Message

Graduate school of Pharmaceutical Sciences, Osaka University, Professor
KAZUTAKE TSUJIKAWA, Ph.D.

Access

Google map

Head Office

2‐2‐1, New Elimo Bid. 8F A2, Senba-nishi, Minoh-shi,
Osaka 5620036 Japan
+81-72-707-2760

Google map

Laboratory in joint research with Wakayama Medical University

401 CIMS 811-1 Kimiidera, Wakayama-shi 641-8509, Japan